Franklin Resources
RGNX icon

Franklin Resources’s Regenxbio RGNX Stock Holding History

Franklin Resources’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$141K Sell
16,801
-2,169
-11% -$22.8K ﹤0.01% 2860
2025
Q4 		$273K Sell
18,970
-9,901
-34% -$123K ﹤0.01% 2664
2025
Q3 		$279K Sell
28,871
-230
-0.8% -$2.03K ﹤0.01% 2693
2025
Q2 		$239K Buy
+29,101
New +$244K ﹤0.01% 2666
2022
Q2 		– Sell
-8,509
Closed -$282K – 2445
2022
Q1 		$282K Sell
8,509
-2,179
-20% -$60.5K ﹤0.01% 2041
2021
Q4 		$349K Buy
10,688
+286
+3% +$9.74K ﹤0.01% 2027
2021
Q3 		$436K Buy
+10,402
New +$374K ﹤0.01% 1948
2020
Q1 		– Sell
-302,276
Closed -$12.4M – 1556
2019
Q4 		$12.4M Sell
302,276
-22,400
-7% -$885K 0.01% 854
2019
Q3 		$11.6M Hold
324,676
– – 0.01% 862
2019
Q2 		$16.7M Sell
324,676
-270,600
-45% -$13.5M 0.01% 785
2019
Q1 		$34.1M Sell
595,276
-65,000
-10% -$3.22M 0.02% 614
2018
Q4 		$27.7M Buy
660,276
+12,600
+2% +$739K 0.02% 628
2018
Q3 		$48.9M Sell
647,676
-95,800
-13% -$6.9M 0.02% 545
2018
Q2 		$53.3M Sell
743,476
-25,400
-3% -$1.21M 0.03% 518
2018
Q1 		$23M Sell
768,876
-101,924
-12% -$2.97M 0.01% 748
2017
Q4 		$29M Sell
870,800
-17,400
-2% -$524K 0.01% 699
2017
Q3 		$29.3M Hold
888,200
– – 0.01% 695
2017
Q2 		$17.5M Sell
888,200
-85,000
-9% -$1.65M 0.01% 823
2017
Q1 		$18.8M Hold
973,200
– – 0.01% 803
2016
Q4 		$18.1M Sell
973,200
-17,600
-2% -$336K 0.01% 818
2016
Q3 		$13.9M Buy
990,800
+290,300
+41% +$3.2M 0.01% 902
2016
Q2 		$5.6M Buy
700,500
+637,100
+1,005% +$7.07M ﹤0.01% 1083
2016
Q1 		$685K Hold
63,400
– – ﹤0.01% 1364
2015
Q4 		$1.05M Sell
63,400
-36,600
-37% -$726K ﹤0.01% 1358
2015
Q3 		$2.2M Buy
+100,000
New +$2.55M ﹤0.01% 1271

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources's RGNX Position: Q1 2026 in Review

Franklin Resources reduced its Regenxbio (RGNX) stake by 11% in Q1 2026, selling an estimated $22.8K and leaving 16,801 shares worth $141K. The position accounts for ﹤0.01% of the portfolio, ranked #2860.

Franklin Resources first reported a position in RGNX in Q3 2015 and has held it in 25 quarters since. The position peaked at $53.3M in Q2 2018. 178 funds tracked by Wall St. Rank hold RGNX as of Q1 2026.

  • Franklin Resources held 16,801 shares of Regenxbio worth $141K as of Q1 2026.
  • Franklin Resources sold 2,169 Regenxbio shares in Q1 2026, an estimated $22.8K.
  • Regenxbio made up ﹤0.01% of Franklin Resources's portfolio in Q1 2026, its #2860 holding.
  • Franklin Resources first reported a position in Regenxbio in Q3 2015 and has held it in 25 quarters since.
  • Franklin Resources's Regenxbio position peaked at $53.3M in Q2 2018.
  • 178 funds tracked by Wall St. Rank held Regenxbio as of Q1 2026.

Based on Franklin Resources's 13F filing for Q1 2026, filed 13 May 2026.